{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:18Z","timestamp":1794047478458,"version":"4.8.0"},"reference-count":59,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>The gut microbiota plays a critical role in maintaining a healthy human body and its dysregulation is associated with various diseases. In this study, we investigated the influence of gut microbiome diversity on the development of chronic lymphocytic leukemia (CLL). Analysis of stool samples from 59 CLL patients revealed individual and heterogeneous microbiome compositions, but allowed for grouping of patients according to their microbiome diversity. Interestingly, CLL patients with lower microbiome diversity and an enrichment of bacteria linked to poor health suffered from a more advanced or aggressive form of CLL. In the E\u00b5-TCL1 mouse model of CLL, we observed a faster course of disease when mice were housed in high hygiene conditions. Shotgun DNA sequencing of fecal samples showed that this was associated with a lower microbiome diversity which was dominated by Mucispirillum and Parabacteroides genera in comparison to mice kept under lower hygiene conditions. In conclusion, we applied taxonomic microbiome analyses to demonstrate a link between gut microbiome diversity and the clinical course of CLL in humans, as well as the development of CLL in mice. Our novel data serve as a basis for further investigations to decipher the pathological and mechanistic role of intestinal microbiota in CLL development.<\/jats:p>","DOI":"10.3324\/haematol.2023.284693","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:15:37Z","timestamp":1715228137000},"page":"3237-3250","source":"Crossref","is-referenced-by-count":20,"title":["The diversity of the microbiome impacts chronic lymphocytic leukemia development in mice and humans"],"prefix":"10.3324","volume":"109","author":[{"given":"Tereza","family":"Faitova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caspar","family":"Da Cunha-Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcen","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Bork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten U.","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"67057","doi-asserted-by":"crossref","unstructured":"Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018; 361:k2179.","DOI":"10.1136\/bmj.k2179"},{"key":"67058","doi-asserted-by":"crossref","unstructured":"Gorkiewicz G, Moschen A. Gut microbiome: a new player in gastrointestinal disease. Virchows Arch. 2018; 472(1):159-172.","DOI":"10.1007\/s00428-017-2277-x"},{"key":"67059","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez JM, Murphy K, Stanton C. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015; 26:26050.","DOI":"10.3402\/mehd.v26.26050"},{"key":"67060","doi-asserted-by":"crossref","unstructured":"Yoo JY, Groer M, Dutra SV, Sarkar A, McSkimming DI. Gut microbiota and immune system interactions. Microorganisms. 2020; 8(10):1587.","DOI":"10.3390\/microorganisms8101587"},{"key":"67061","doi-asserted-by":"crossref","unstructured":"Br\u00fcssow H. Problems with the concept of gut microbiota dysbiosis. Microb Biotechnol. 2020; 13(2):423-434.","DOI":"10.1111\/1751-7915.13479"},{"key":"67062","doi-asserted-by":"crossref","unstructured":"Bonnet M, Buc E, Sauvanet P. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014; 20(4):859-867.","DOI":"10.1158\/1078-0432.CCR-13-1343"},{"key":"67063","doi-asserted-by":"crossref","unstructured":"Wang R, Yang X, Liu J. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022; 13(1):2522.","DOI":"10.1038\/s41467-022-30240-8"},{"key":"67064","doi-asserted-by":"crossref","unstructured":"Vicente-Due\u00f1as C, Janssen S, Oldenburg M. An intact gut microbiome protects genetically predisposed mice against leukemia. Blood. 2020; 136(18):2003-2017.","DOI":"10.1182\/blood.2019004381"},{"key":"67065","doi-asserted-by":"crossref","unstructured":"Park JS, Gazzaniga FS, Wu M. Targeting PD-L2\u2013RGMb overcomes microbiome-related immunotherapy resistance. Nature. 2023; 617(7960):377-385.","DOI":"10.1038\/s41586-023-06026-3"},{"key":"67066","doi-asserted-by":"crossref","unstructured":"Faitov\u00e1 T, Svanberg R, da Cunha-Bang C. The gut microbiome in patients with chronic lymphocytic leukemia. Haematologica. 2022; 107(9):2238-2243.","DOI":"10.3324\/haematol.2021.280455"},{"key":"67067","doi-asserted-by":"crossref","unstructured":"Caligaris-Cappio F. Inflammation, the microenvironment and chronic lymphocytic leukemia. Haematologica. 2011; 96(3):353-355.","DOI":"10.3324\/haematol.2010.039446"},{"key":"67068","doi-asserted-by":"crossref","unstructured":"Niemann CU, Wiestner A. B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol. 2013; 23(6):410-421.","DOI":"10.1016\/j.semcancer.2013.09.001"},{"key":"67069","doi-asserted-by":"crossref","unstructured":"Svanberg R, Janum S, Patten PEM, Ramsay AG, Niemann CU. Targeting the tumor microenvironment in chronic lymphocytic leukemia. Haematologica. 2021; 106(9):2312-2324.","DOI":"10.3324\/haematol.2020.268037"},{"key":"67070","doi-asserted-by":"crossref","unstructured":"Aghamajidi A, Maleki Vareki S. The effect of the gut microbiota on systemic and anti-tumor immunity and response to systemic therapy against cancer. Cancers (Basel). 2022; 14(15):3563.","DOI":"10.3390\/cancers14153563"},{"key":"67071","doi-asserted-by":"crossref","unstructured":"Schulthess J, Pandey S, Capitani M. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019; 50(2):432-445.","DOI":"10.1016\/j.immuni.2018.12.018"},{"key":"67072","doi-asserted-by":"crossref","unstructured":"Modoux M, Rolhion N, Lefevre JH. Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands. Gut Microbes. 2022; 14(1):2105637.","DOI":"10.1080\/19490976.2022.2105637"},{"key":"67073","doi-asserted-by":"crossref","unstructured":"Andersen MA, Rostgaard K, Niemann CU, Hjalgrim H. Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. Leukemia. 2021; 35(3):747-751.","DOI":"10.1038\/s41375-020-0980-0"},{"key":"67074","doi-asserted-by":"crossref","unstructured":"da Cunha-Bang C, Geisler CH, Enggaard L. The Danish National Chronic Lymphocytic Leukemia Registry. Clin Epidemiol. 2016; 8:561-565.","DOI":"10.2147\/CLEP.S99486"},{"key":"67075","doi-asserted-by":"crossref","unstructured":"Ilett EE, J\u00f8rgensen M, Noguera-Julian M. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv. 2020; 4(22):5797-5809.","DOI":"10.1182\/bloodadvances.2020002677"},{"key":"67076","doi-asserted-by":"crossref","unstructured":"Hanna BS, McClanahan F, Yazdanparast H. Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo. Leukemia. 2016; 30(3):570-579.","DOI":"10.1038\/leu.2015.305"},{"key":"67077","doi-asserted-by":"crossref","unstructured":"Bichi R, Shinton SA, Martin ES. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A. 2002; 99(10):6955-6960.","DOI":"10.1073\/pnas.102181599"},{"key":"67078","doi-asserted-by":"crossref","unstructured":"McClanahan F, Hanna B, Miller S. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia. Blood. 2015; 126(2):203-211.","DOI":"10.1182\/blood-2015-01-622936"},{"key":"67079","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen M, N\u00f8rgaard JC, Ilett EE. Metabolic potential of the gut microbiome is significantly impacted by conditioning regimen in allogeneic hematopoietic stem cell transplantation recipients. Int J Mol Sci. 2022; 23(19):11115.","DOI":"10.3390\/ijms231911115"},{"key":"67080","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000; 28(1):27-30.","DOI":"10.1093\/nar\/28.1.27"},{"key":"67081","doi-asserted-by":"crossref","unstructured":"Darzi Y, Falony G, Vieira-Silva S, Raes J. Towards biome-specific analysis of meta-omics data. ISME J. 2016; 10(5):1025-1028.","DOI":"10.1038\/ismej.2015.188"},{"key":"67082","unstructured":"Oksanen J, Simpson GL, Blanchet FG. vegan: Community Ecology Package. R package version 2.6-2.Publisher Full Text|"},{"key":"67083","doi-asserted-by":"crossref","unstructured":"Gruber B, Unmack PJ, Berry OF, Georges A. dartr: an r package to facilitate analysis of SNP data generated from reduced representation genome sequencing. Mol Ecol Resour. 2018; 18(3):691-699.","DOI":"10.1111\/1755-0998.12745"},{"key":"67084","doi-asserted-by":"crossref","unstructured":"Wirbel J, Zych K, Essex M. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. 2021; 22(1):93.","DOI":"10.1186\/s13059-021-02306-1"},{"key":"67085","doi-asserted-by":"crossref","unstructured":"Uribe-Herranz M, Klein-Gonz\u00e1lez N, Rodr\u00edguez-Lobato LG, Juan M, de Larrea CF. Gut microbiota influence in hematological malignancies: from genesis to cure. Int J Mol Sci. 2021; 22(3):1026.","DOI":"10.3390\/ijms22031026"},{"key":"67086","doi-asserted-by":"crossref","unstructured":"Gacesa R, Kurilshikov A, Vich Vila A. Environmental factors shaping the gut microbiome in a Dutch population. Nature. 2022; 604(7907):732-739.","DOI":"10.1038\/s41586-022-04567-7"},{"key":"67087","doi-asserted-by":"crossref","unstructured":"Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S. Short chain fatty acids and its producing organisms: an overlooked therapy for IBD?. EBioMedicine. 2021; 66:103293.","DOI":"10.1016\/j.ebiom.2021.103293"},{"key":"67088","doi-asserted-by":"crossref","unstructured":"Fusco W, Lorenzo MB, Cintoni M. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023; 15(9):2211.","DOI":"10.3390\/nu15092211"},{"key":"67089","doi-asserted-by":"crossref","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018; 9(1):3294.","DOI":"10.1038\/s41467-018-05470-4"},{"key":"67090","doi-asserted-by":"crossref","unstructured":"Vieira-Silva S, Falony G, Darzi Y. Species\u2013function relationships shape ecological properties of the human gut microbiome. Nat Microbiol. 2016; 1(8):16088.","DOI":"10.1038\/nmicrobiol.2016.88"},{"key":"67091","doi-asserted-by":"crossref","unstructured":"Dewhirst FE, Chien CC, Paster BJ. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol. 1999; 65(8):3287-3292.","DOI":"10.1128\/AEM.65.8.3287-3292.1999"},{"key":"67092","doi-asserted-by":"crossref","unstructured":"Ege MJ. The hygiene hypothesis in the age of the microbiome. Ann Am Thorac Soc. 2017; 14(Supplement_5):S348-S353.","DOI":"10.1513\/AnnalsATS.201702-139AW"},{"key":"67093","doi-asserted-by":"crossref","unstructured":"Mohajeri MH, Brummer RJM, Rastall RA. The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr. 2018; 57(Suppl 1):1-14.","DOI":"10.1007\/s00394-018-1703-4"},{"key":"67094","doi-asserted-by":"crossref","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022; 12(1):31-46.","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"67095","doi-asserted-by":"crossref","unstructured":"Saus E, Iraola-Guzm\u00e1n S, Willis JR, Brunet-Vega A, Gabald\u00f3n T. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol Aspects Med. 2019; 69:93-106.","DOI":"10.1016\/j.mam.2019.05.001"},{"key":"67096","doi-asserted-by":"crossref","unstructured":"Liu Y, Baba Y, Ishimoto T. Gut microbiome in gastrointestinal cancer: a friend or foe?. Int J Biol Sci. 2022; 18(10):4101-4117.","DOI":"10.7150\/ijbs.69331"},{"key":"67097","doi-asserted-by":"crossref","unstructured":"Wheatley RC, Kilgour E, Jacobs T. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy. Br J Cancer. 2022; 126(5):693-705.","DOI":"10.1038\/s41416-021-01583-8"},{"key":"67098","doi-asserted-by":"crossref","unstructured":"Diefenbach CS, Peters BA, Li H. Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma. Blood Adv. 2021; 5(5):1194-1198.","DOI":"10.1182\/bloodadvances.2020003129"},{"key":"67099","doi-asserted-by":"crossref","unstructured":"Montassier E, Gastinne T, Vangay P. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015; 42(5):515-528.","DOI":"10.1111\/apt.13302"},{"key":"67100","doi-asserted-by":"crossref","unstructured":"Galloway-Pe\u00f1a JR, Shi Y, Peterson CB. Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clin Infect Dis. 2020; 71(1):63-71.","DOI":"10.1093\/cid\/ciz777"},{"key":"67101","doi-asserted-by":"crossref","unstructured":"Rajagopala SV, Singh H, Yu Y. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy. Microb Ecol. 2020; 79(4):1034-1043.","DOI":"10.1007\/s00248-019-01448-x"},{"key":"67102","doi-asserted-by":"crossref","unstructured":"Yang Y, Du L, Shi D. Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat Commun. 2021; 12(1):6757.","DOI":"10.1038\/s41467-021-27112-y"},{"key":"67103","doi-asserted-by":"crossref","unstructured":"Vals-Delgado C, Alcala-Diaz JF, Molina-Abril H. An altered microbiota pattern precedes type 2 diabetes mellitus development: from the CORDIOPREV study. J Adv Res. 2021; 35:99-108.","DOI":"10.1016\/j.jare.2021.05.001"},{"key":"67104","doi-asserted-by":"crossref","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017; 19(1):29-41.","DOI":"10.1111\/1462-2920.13589"},{"key":"67105","doi-asserted-by":"crossref","unstructured":"Shetty SA, Kuipers B, Atashgahi S, Aalvink S, Smidt H, de Vos WM. Inter-species metabolic interactions in an in-vitro minimal human gut microbiome of core bacteria. NPJ Biofilms Microbiomes. 2022; 8(1):21.","DOI":"10.1038\/s41522-022-00275-2"},{"key":"67106","doi-asserted-by":"crossref","unstructured":"Rodriguez-Palacios A, Aladyshkina N, Ezeji JC. \u2018Cyclical bias\u2019 in microbiome research revealed by a portable germ-free housing system using nested isolation. Sci Rep. 2018; 8(1):3801.","DOI":"10.1038\/s41598-018-20742-1"},{"key":"67107","doi-asserted-by":"crossref","unstructured":"Tomasi M, Dalsass M, Beghini F. Commensal Bifidobacterium strains enhance the efficacy of neo-epitope based cancer vaccines. Vaccines (Basel). 2021; 9(11):1356.","DOI":"10.3390\/vaccines9111356"},{"key":"67108","doi-asserted-by":"crossref","unstructured":"Danne C, Ryzhakov G, Mart\u00ednez-L\u00f3pez M. A large polysaccharide produced by Helicobacter hepaticus induces an anti-inflammatory gene signature in macrophages. Cell Host Microbe. 2017; 22(6):733-745.","DOI":"10.1016\/j.chom.2017.11.002"},{"key":"67109","doi-asserted-by":"crossref","unstructured":"Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014; 345(2):196-202.","DOI":"10.1016\/j.canlet.2013.08.016"},{"key":"67110","doi-asserted-by":"crossref","unstructured":"Peters BA, Pass HI, Burk RD. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. Genome Med. 2022; 14(1):121.","DOI":"10.1186\/s13073-022-01126-7"},{"key":"67111","doi-asserted-by":"crossref","unstructured":"Giri S, Mangalam A. Chapter 4. The gut microbiome and metabolome in multiple sclerosis. 2019;333-340.","DOI":"10.1016\/B978-0-12-815249-2.00034-8"},{"key":"67112","doi-asserted-by":"crossref","unstructured":"Daniel SG, Ball CL, Besselsen DG, Doetschman T, Hurwitz BL. Functional changes in the gut microbiome contribute to transforming growth factor \u03b2-deficient colon cancer. mSystems. 2017; 2(5):e00065-17.","DOI":"10.1128\/mSystems.00065-17"},{"key":"67113","doi-asserted-by":"crossref","unstructured":"Koh GY, Kane A, Lee K. Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice. Int J Cancer. 2018; 143(7):1797-1805.","DOI":"10.1002\/ijc.31559"},{"key":"67114","doi-asserted-by":"crossref","unstructured":"Ley RE, B\u00e4ckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102(31):11070-11075.","DOI":"10.1073\/pnas.0504978102"},{"key":"67115","doi-asserted-by":"crossref","unstructured":"Nguyen TL, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research?. Dis Model Mech. 2015; 8(1):1-16.","DOI":"10.1242\/dmm.017400"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284693\/76978","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284693\/77569","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11582\/76978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:24Z","timestamp":1794045984000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284693","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}